Carcinoma cell lines and primary tumours exhibit hemizygous or homozygous deletion with end points within fragile regions of the human genome, particularly within the most active common fragile site, FRA3B, encompassed by the FHIT gene (Iliopoulos et al, 2006). The gene discussed is FHIT; the disease is neoplasm.